Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
11/2000
11/09/2000CA2371604A1 Integrin receptor antagonists
11/08/2000EP1049484A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
11/08/2000EP1049378A2 An antimicrobial composition
11/08/2000CN1272793A Method of protecting against chronic infections
11/08/2000CN1058266C 14-substituted marcfortines and derivatives useful as antiparasitic agents and its application
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000012508B1 Pyrrolbenzodiazepines
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
10/2000
10/31/2000US6140365 Preparation of microorganisms comprising omega-3-fatty acid for use as a prophylactic or therapeutic agent against parasitic diseases of animals
10/31/2000US6140339 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/31/2000US6139844 Method for treating or eliminating a parasitic disease
10/31/2000US6139840 Administering a therapeutic compositions to protect a host animal from flea infestation
10/31/2000CA2224565C Agent for combating parasites in farmed fish
10/31/2000CA2096345C Avermectins and milbemycins to treat parasitic in dogs
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063244A1 Parasite antigens
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062616A1 (s)-enantiomer enriched fipronil composition
10/26/2000WO2000037064A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2364191A1 Parasite antigens
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045837A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/25/2000CN1057682C Drug for curing toxocariasis
10/24/2000US6136847 Water-soluble trioxanes as potent and safe antimalarial agents
10/24/2000US6136836 A 1-(3-chloro-4-(1,1,2-trifluoro-2-fluoromethoxyethoxy)phenyl-3-(2,6-difluorobenzoyl)urea
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061184A2 Dry formulation for transcutaneous immunization
10/19/2000WO2000061134A1 Antimicrobial agents
10/19/2000WO2000061133A1 Combination preparation for treating malaria
10/19/2000WO2000060952A1 Method of using emamectin to treat fish parasites
10/19/2000WO2000037063A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000012507A8 Pyrrolobenzodiazepines
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2369089A1 Combination preparation for treating malaria
10/19/2000CA2368655A1 Dry formulation for transcutaneous immunization
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044977A1 Camptothecin derivatives having antitumor activity
10/18/2000EP1044685A2 Farnesol derivatives for morphological transition control over dimorphic fungi
10/18/2000EP1044208A1 Erythromycin derivatives
10/18/2000EP1044207A1 Novel macrolides
10/18/2000EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
10/18/2000CN1057520C N, N'-substituted imidocarbonimidic diaides derivative from hydroxylamines, its medicinal composition and uses
10/18/2000CN1057468C Chinese medicinal preparation for curing eczematous dermitis of young pigs
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6132733 Ringworm vaccine
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059916A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059501A1 Water-soluble trioxanes as potent and safe antimalarial agents
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059468A1 Drinkable pharmaceutical solution
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1042323A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000058328A2 Avermectin derivatives
10/05/2000WO2000058291A1 Pesticidal enantiomer-pure 2,4-disubstituted oxazolines
10/05/2000WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000030625A3 Use of phosphonoformic acid derivatives for treating infections
10/05/2000WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
10/05/2000DE19913534A1 Avermectinderivate Avermectin derivatives
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2368465A1 Avermectin derivatives
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/04/2000EP1040198A1 Recombinant rhabdovirus containing a heterologous fusion protein
10/04/2000EP1040123A2 Human papillomavirus vaccine
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1039930A2 Adjuvanted vaccine formulation
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 218